Status:
COMPLETED
Rehabilitation Needs After COVID-19 Hospital Treatment
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Conditions:
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
The onset of Coronavirus Disease 2019 (COVID-19) in the first months of 2020 had a huge impact on Italian population and Healthcare System, with more than 150.000 total confirmed cases1. SARS-CoV-2 is...
Detailed Description
The onset of Coronavirus Disease 2019 (COVID-19) in the first months of 2020 had a huge impact on Italian population and Healthcare System, with more than 150.000 total confirmed cases. SARS-CoV-2 is ...
Eligibility Criteria
Inclusion
- age\>18,
- positive at COVID-19
- manifesting symptoms that required hospitalization, that is history of fever or pneumonia or other symptoms COVID-19 related.
Exclusion
- asymptomatic individuals COVID-19 positive that were hospitalized for reasons other than COVID-19;
- dementia;
- psychiatric disorders
- other diseases preventing people to participate to the rehabilitation assessments provided by this protocol;
- acute or post-acute clinical conditions causing disability itself (e.g.: major neurological disease, such as recent stroke, TBI, etc., or recent surgical intervention, or heart failure, etc.),
- previous complete dependence in ADLs .
Key Trial Info
Start Date :
June 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04438239
Start Date
June 22 2020
End Date
December 31 2020
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL-IRCCS S.Maria Nuova Hospital
Reggio Emilia, Italy, 42123